Remove 2020 Remove FDA Remove Immunization
article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. REFERENCES 1.

FDA 341
article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

from 2017 to 2020. Authors of a Journal of the American Medical Association study found that adolescent use of GLP-1s “increased substantially” between 2020 and 2023. Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023. April 2, 2024. Accessed June 25, 2025. 2024;331(23):2041–2043.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

1 Natural disasters have reached unprecedented levels in the past 5 years, with 2020, 2023, and 2024 being the most destructive and costly since before 1980. Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote.

article thumbnail

GLP-1s Associated With Increased Risk of Neovascular Age-Related Macular Degeneration

Drug Topics

Data for the study was gathered from comprehensive administrative health and demographic data in Canada by the Institute for Clinical Evaluative Sciences from January 2020 to November 2023.

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Updated October 23, 2020. ClinicalTrials.gov identification: NCT00160108. Updated March 20, 2018. Accessed June 12, 2025. Diet and Body Composition (CENTRAL). ClinicalTrials.gov identification: NCT01530724. Accessed June 12, 2025. Effects of Green-MED Diet Via the Gut-fat-brain Axis (DIRECT-PLUS). Updated July 15, 2019.

article thumbnail

The top 5 pharma M&A deals of 2020

pharmaphorum

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. Here we take a look at the biggest mergers and acquisitions of 2020 and what they might mean for the companies involved.

article thumbnail

Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes

Drug Topics

According to an article in BJOG: An International Journal of Obstetrics and Gynaecology , the rate of pregestational and gestational diabetes has been increasing in the US, occurring in 1% and 8% of all pregnant women in 2020, respectively.